openPR Logo
Press release

LDL Apheresis Therapy Market to Record an Exponential CAGR by 2025

08-27-2018 07:01 PM CET | Health & Medicine

Press release from: Transparency Market Research

LDL Apheresis Therapy Market to Record an Exponential CAGR

High level of low density lipoprotein (LDL) cholesterol in blood may turn life-threatening, as it deposits in the blood vessels, narrowing the lumen, and leads to coronary heart diseases. This condition is commonly called atherosclerosis. LDL apheresis is a procedure that involves withdrawing blood from the patient’s body, removing LDL cholesterol and pumping the remaining blood back into the patient’s body. The LDL apheresis procedure is recommended to patients with familial hypercholesterolemia (FH), a common genetic disorder that leads to a high level of LDL cholesterol. This procedure is also performed for patients who are non-responsive to medications for lowering blood LDL cholesterol levels. The heterozygous type of FH has prevalence of 1 in 500 across all the countries, while the homozygous FH is found in 1 in 10 million population.

View Report -

https://www.transparencymarketresearch.com/ldl-apheresis-therapy-market.html

According to the World Health Organization, in 2008, the prevalence of elevated total cholesterol was 54% in Europe, 48% in North America, and 29% in Southeast Asia. It is estimated that one-third of the heart diseases are caused due to elevated level of cholesterol in the blood. Lifestyle-induced diseases, pollution, and other metabolic diseases are further projected to increase the number of patients with atherosclerosis. Other application areas for LDL apheresis therapy are under study such as renal diseases, hematology diseases, and others. This is projected to drive the demand for LDL apheresis machines and disposables in the near future. Moreover, favorable reimbursement scenario in developed markets such as North America and Europe is driving more patients to opt for LDL apheresis therapy. However, the procedure attracts high capital investment in terms of device and set up. It also attract expensive consumables and skilled healthcare professionals to perform the procedure, which in turn makes the procedure expensive.

The global LDL apheresis therapy market is segmented on the basis of product, technology, and end-user. In terms of product, the global LDL apheresis therapy market can be segmented into devices and disposables, the disposable segment include columns, filters, tubing, etc. In terms of technology, the global LDL apheresis therapy market can be segmented into double filtration plasmapheresis or cascade filtration, immunoadsorption, heparin-induced LDL precipitation (HELP), dextran sulphate lipid adsorption, and hemoperfusion. The hemoperfusion is performed by advanced procedures such as direct adsorption of lipoproteins (DALI) and whole blood perfusion (Liposorber D). Dextran sulfate lipid adsorption and HELP are the most widely employed techniques for LDL apheresis in recent years. However, technically advanced hemoperfusion systems are found to be more promising and are anticipated to dominate the market in near future due to their efficiency and simplicity of use. In terms of end-user, the global LDL apheresis therapy market can be segmented into hospitals, ambulatory surgical centers, and blood banks.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28493

In terms of geography, the global LDL apheresis therapy market can be segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is estimated to hold a prominent share of the global LDL apheresis therapy market and is anticipated to expand at a high growth rate due to acceptance of technology, well-established healthcare industry, and high healthcare expenditure from the public and private sector. Europe is projected to follow North America in terms of share of the global LDL apheresis therapy market due to increasing prevalence of elevated cholesterol in blood and developments in healthcare infrastructure. Technical advancements in markets such as Japan and increasing healthcare expenditure in emerging markets such as India and China are likely to propel the LDL apheresis therapy market in Asia Pacific in the near future.

Major players operating in the global LDL apheresis therapy market include Kaneka Pharma Europe N.V, B. Braun Melsungen AG, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Medical Co., Ltd., Medicap GmbH, Kawasumi Laboratories Inc. Terumo Corporation, and Haemonetics Corporation.

Request to View ToC of the report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=28493

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release LDL Apheresis Therapy Market to Record an Exponential CAGR by 2025 here

News-ID: 1204390 • Views:

More Releases from Transparency Market Research

Application Performance Monitoring Market Outlook 2031: Trends, Growth Drivers, …
In today's digital era, the performance of applications is pivotal for businesses, with speed, functionality, and user experience often determining success. The global Application Performance Monitoring (APM) Market is gaining momentum as enterprises increasingly rely on high-performing applications to drive productivity and customer satisfaction. According to recent market insights, the APM market, valued at US$ 5.9 billion in 2021, is anticipated to grow at a robust CAGR of 12.1% from
3D Reconstruction Technology Market Report: Innovations and Growth Opportunities …
As digital transformation and advanced imaging continue to redefine industries worldwide, 3D reconstruction technology stands out as a powerful enabler of immersive experiences, data accuracy, and operational efficiency. This technology, which spans components such as software and services, facilitates the generation of realistic 3D models from 2D images, scanned data, and videos. The global 3D reconstruction technology market, valued at US$ 995.4 million in 2021, is set to grow rapidly.
Oxycodone Hydrochloride Market Trends in Non-Opioid Alternatives - Predicted to expand to USD 675.2 million by 2034
Oxycodone Hydrochloride Market Trends in Non-Opioid Alternatives - Predicted to …
The Oxycodone Hydrochloride Market is set for moderate growth over the next decade, driven by the ongoing demand for effective pain management solutions and the increasing prevalence of chronic pain conditions. Valued at USD 403.9 million in 2023, the market is expected to grow at a compound annual growth rate (CAGR) of 4.8% from 2024 to 2034, reaching an estimated USD 675.2 million by the end of the forecast period.
Oxidative Stress Assays Market Future Directions in Cell-Based Assay Solutions - Estimated growth to USD 2.8 billion by 2034
Oxidative Stress Assays Market Future Directions in Cell-Based Assay Solutions - …
The global Oxidative Stress Assays Market is experiencing robust growth, driven by the rising demand for diagnostics and therapeutics focused on oxidative stress-related diseases. With a market valuation of USD 1.0 billion in 2023 and a projected compound annual growth rate (CAGR) of 9.4% through 2034, the market is anticipated to reach USD 2.8 billion by the end of the forecast period. This growth reflects a broader recognition of oxidative

All 5 Releases


More Releases for LDL

LDL Test Market Size, Growth, Report Study, Demand, Key Players, and Forecast by …
LDL Test Market The global LDL Test market is comprehensive and Insightful information in the report, taking into consideration various factors such as competition, regional growth, segmentation, and LDL Test Market size by value and volume. This is an excellent study specially designed to provide you with up-to-date information on important aspects of the LDL Test market. This report presents various market forecasts related to market size, production, revenue, consumption, CAGR, gross
LDL Test Market Size, Outlook, Analysis Report, Regional Outlook With Forecast 2 …
LDL Test Market The global LDL Test market is comprehensive and Insightful information in the report, taking into consideration various factors such as competition, regional growth, segmentation, and LDL Test Market size by value and volume. This is an excellent study specially designed to provide you with up-to-date information on important aspects of the LDL Test market. This report presents various market forecasts related to market size, production, revenue, consumption, CAGR, gross
LDL Apheresis Therapy Market Healthcare, Clinical Reviews, Survey Reports 2020-2 …
LDL Apheresis Therapy Market Size, Status, Business Future Scenarios and Brief Analysis 2020-2026 The report begins with the overview of the LDL Apheresis Therapy Market and offers throughout development. It presents a comprehensive analysis of all the regional and major player segments that gives closer insights upon present market conditions and future market opportunities along with drivers, trending segments, consumer behavior, pricing factors and market performance and estimation. The forecast market
What will be the success factors for the LDL Test Market?
LDL Test Market 2019-2026 The Global LDL Test Market research report provides a unique methodology for evaluating the market insights, highlighting opportunities and supporting strategic and tactical decision-making. This report recognizes the requirement of a rapidly-evolving and competitive environment, up-to-date marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides information on the latest trends and developments and focuses on innovations with emerging new
Global Ldl Test Market Industry Trend and Forecast 2025
This report focuses on the global LDL Test status, future forecast, growth opportunity, key market and key players. The study objectives are to present the LDL Test development in United States, Europe and China. LDL stands for low-density lipoprotein, a type of cholesterol found in the body. LDL is often referred to as bad cholesterol. This is because too much LDL results in a build-up of cholesterol in arteries, which can
LDL Apheresis Therapy Market Estimated to Rise Profitably during the Foreseeable …
High level of low density lipoprotein (LDL) cholesterol in blood may turn life-threatening, as it deposits in the blood vessels, narrowing the lumen, and leads to coronary heart diseases. This condition is commonly called atherosclerosis. LDL apheresis is a procedure that involves withdrawing blood from the patient’s body, removing LDL cholesterol and pumping the remaining blood back into the patient’s body. The LDL apheresis procedure is recommended to patients with